VM4-037

DB15319InvestigationalSmall molecule

VM4-037 is under investigation in clinical trial NCT00884520 (An Exploratory, Open Label, Multi-Center, Non-Randomized Study of [F-18]VM4-037).

Mechanism: Pharmacologically active on Carbonic anhydrase 12 and Carbonic anhydrase 9
Curator reviewed
Formula / weight: C₂₆H₂₉FN₆O₇S₂ · 620.67 g/mol (avg)
Code names: VM4-037

Resolves to

Compound

Structure

InChIKeyQGYZPMXIVNIGKA-GMAHTHKFSA-NSMILESCC(C)[C@H](N1C=C(COC2=CC3=C(C=C2)N=C(S3)S(N)(=O)=O)N=N1)C(=O)N[C@@H](CC1=CC=C(OCCF)C=C1)C(O)=O

Targets

What you can answer from here — as of July 08, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with VM4-037, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.